保脾远端胰腺切除术中保留或不保留脾血管的长期结局:双机构经验
该回顾性双机构研究纳入297例保脾远端胰腺切除术患者,比较Warshaw技术与Kimura技术的短期和长期结局。Warshaw多用于较大、近端、恶性或复杂病变,Kimura多用于微创和小远端良性肿瘤。两者短期并发症相当,但Warshaw术后脾灌注不足更常见,需二次脾切除罕见。
要点
- Warshaw技术适用于近端、恶性或复杂病变,Kimura适用于小远端良性肿瘤。
- Warshaw术后脾灌注不足发生率30.4%,高于Kimura的12.2%。
- 两种技术短期并发症、再入院和死亡率相当,二次脾切除罕见(1.2%)。
核心结论
- Warshaw和Kimura技术用于保脾远端胰腺切除术均安全有效。
- Warshaw适用于近端、恶性或复杂病变,Kimura可能减少小远端良性肿瘤的长期脾脏后遗症。
- 基于解剖和疾病的个体化术式选择至关重要。
研究设计与样本
- 回顾性双机构分析,纳入2002至2020年马萨诸塞总医院和西达赛奈医疗中心297例保脾远端胰腺切除术患者。
- 比较Warshaw技术(245例,82.5%)与Kimura技术(52例,17.5%)的临床病理、手术和影像学结局。
主要发现
- Warshaw组肿瘤更大(2.5 cm vs. 1.5 cm,P<0.001),标本更长(8.2 cm vs. 5.7 cm,P<0.001),更常用于恶性或复杂疾病。
- Kimura组微创手术比例更高(73.1% vs. 44.1%,P<0.001),手术时间更短。
- 中位随访85.8个月,Warshaw组脾灌注不足更常见(30.4% vs. 12.2%,P=0.010),胃周静脉曲张有更高趋势(19.6% vs. 7.3%,P=0.056),但多无临床症状。
- 二次脾切除需求罕见(1.2%),短期并发症、再入院和死亡率两组相当。
关键数值与推荐
- Warshaw组肿瘤大小2.5 cm,Kimura组1.5 cm(P<0.001)。
- Warshaw组标本长度8.2 cm,Kimura组5.7 cm(P<0.001)。
- Kimura组微创手术比例73.1%,Warshaw组44.1%(P<0.001)。
- 脾灌注不足发生率Warshaw组30.4%,Kimura组12.2%(P=0.010)。
- 胃周静脉曲张发生率Warshaw组19.6%,Kimura组7.3%(P=0.056)。
临床怎么用
- 对于近端、恶性或复杂病变,可选择Warshaw技术,但需关注长期脾灌注不足和胃周静脉曲张。
- 对于小、远端、良性肿瘤,Kimura技术可能减少长期脾脏后遗症。
- 术式选择应基于解剖和疾病特征个体化决定。
局限性
- 回顾性研究设计。
- 两组样本量不平衡(Warshaw 245例 vs. Kimura 52例)。
- 选择偏倚可能存在,因Warshaw更常用于复杂病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the short- and long-term outcomes of the Warshaw (splenic vessel resection) and Kimura (splenic vessel preservation) techniques in spleen-preserving distal pancreatectomy (SPDP). SUMMARY BACKGROUND DATA: SPDP is an alternative to splenectomy that preserves immune function. Both Warshaw and Kimura are used, but comparative data on their long-term safety and indications are limited. METHODS: Retrospective bi-institutional analysis of 297 patients undergoing SPDP at Massachusetts General Hospital and Cedars-Sinai Medical Center (2002-2020). Clinicopathologic, operative, and radiologic outcomes were compared. RESULTS: Of 297 patients, 245 (82.5%) underwent Warshaw and 52 (17.5%) Kimura. Warshaw was more commonly performed for larger tumors (2.5 cm vs. 1.5 cm, P<0.001), proximal lesions (specimen 8.2 cm vs. 5.7 cm, P<0.001), and malignant or complex disease, Kimura was more commonly performed minimally invasively (MIS) (73.1% vs. 44.1%, P<0.001) and was associated with shorter operative time. Higher ASA class, larger tumor size, pancreatic ductal adenocarcinoma, and the Warshaw technique independently predicted longer operative time in MIS cases, suggesting a preferential adoption of the Warshaw technique for technically more challenging tumor dissections. Short-term morbidity, readmission, and mortality rates were comparable. With a median follow-up of 85.8 monthssplenic hypoperfusion (30.4% vs. 12.2%, P=0.010), and perigastric varices (19.6% vs. 7.3%, P=0.056) were more frequent after Warshaw, although most were clinically silent, and the need for secondary splenectomy was rare (1.2%). CONCLUSIONS: Both techniques are safe and effective for SPDP. Warshaw is preferred for proximal, malignant, or complex lesions, while Kimura may minimize long-term splenic sequelae in small, distal, benign tumors. An anatomy- and disease-driven approach remains essential to optimize outcomes.
引用
- Arya S, Ventin M, Zhang L, et al. Long-term Outcomes of Spleen-preserving Distal Pancreatectomy With or Without Preservation of Splenic Vessels: A Bi-institutional Experience. Ann Surg. 2025. PMID: 41373100. doi:10.1097/SLA.0000000000006992
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。